MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Current Status and Expectations for Low-Risk TAVI Trials
An expert opinion on how current clinical trials will impact the future of TAVI procedures in low-risk patients.
With Marc Dweck, MD, PhD
Worldwide Trends in TAVR
By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC
EVOLVED Evaluates Early Aortic Valve Intervention in Patients With Asymptomatic Severe AS and Myocardial Fibrosis
October 28, 2024—The EVOLVED trial found that early aortic valve intervention in patients with asymptomatic, severe aortic stenosis (AS) and midwall myocardial fibrosis on MRI did not reduce the incidence of the composite primary endpoint of all-cause death or unplanned AS hospitalization compared with guideline-directed conservative management.
Legislation Proposing Medical Device Priority Review Moves to Full Senate
March 9, 2016—Senators Orrin Hatch (R-Utah), Michael Bennet (D-Colorado), and Richard Burr (R-North Carolina) announced that the US Senate’s Health, Education, Labor, and Pensions Committee has sent the bipartisan Advancing Breakthrough Devices for Patients Act to the full Senate.
